Hofseth BioCare ASA
HBC
Rank in Stocks
#22773
Hofseth BioCare ASA, an international firm based in Norway, specializes in... Hofseth BioCare ASA, an international firm based in Norway, specializes in developing and supplying premium biomarine ingredients for both human and animal health. The company's product portfolio features various specialized offerings, including Brilliant salmon oil and OmeGo salmon oil, which promotes healthy cholesterol levels and supports cardiovascular well-being. ProGo, a salmon protein hydrolysate, serves as a rapidly assimilated protein supplement. For skeletal and joint health, Hofseth offers CalGo, a marine calcium powder. CollaGo, a collagen peptide powder, is designed to improve the appearance of hair, skin, and nails. Additionally, PetGo provides a non-soluble protein formulation. Distribution of these products is managed through a multi-channel approach, utilizing a network of distributors, agents, and its dedicated internal sales team. Hofseth BioCare also holds a significant research collaboration with Stanford University School of Medicine, focusing on pre-clinical and clinical studies related to conditions such as necrotizing enterocolitis and irritable bowel syndrome. Established in 2000, the company's main operations are based in Ålesund, Norway.
Share Price
$0.1212456
Last synced: 2026-11-09
Market Cap
$49.83M
Change (1 day)
4.28%
Change (1 year)
-31.48%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Hofseth BioCare ASA (HBC)
Category
Consumer Defensive
EPS for Hofseth BioCare ASA (HBC)
EPS as of June 2026 TTM: $-0.04
According to Hofseth BioCare ASA's latest financial reports, its current EPS (TTM) is $-0.04. At the end of 2025 the company had an EPS of $-0.03, equal to its 2024 EPS of $-0.03.
EPS history for Hofseth BioCare ASA from 2010 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.04 | 19.00% |
| 2025 | $-0.03 | 23.40% |
| 2024 | $-0.03 | 0.00% |
| 2023 | $-0.03 | -30.08% |
| 2022 | $-0.04 | -4.53% |
| 2021 | $-0.04 | 10.58% |
| 2020 | $-0.04 | 7.16% |
| 2019 | $-0.03 | -13.66% |
| 2018 | $-0.04 | 351.16% |
| 2017 | $-0.01 | -92.64% |
| 2016 | $-0.12 | 8.74% |
| 2015 | $-0.11 | 9.81% |
| 2014 | $-0.10 | -17.31% |
| 2013 | $-0.12 | -48.90% |
| 2012 | $-0.23 | 208.11% |
| 2011 | $-0.08 | 32.86% |
| 2010 | $-0.06 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.49 | -9,872.27% |
CH
|
|
| $3.40 | -9,627.17% |
FR
|
|
| $2.37 | -6,738.66% |
BR
|
|
| $0.24 | -759.66% |
CN
|
|
| $0.18 | -608.40% |
CN
|
Questions about Hofseth BioCare ASA's earnings per share (EPS)
What is Hofseth BioCare ASA's earnings per share (EPS)?
Hofseth BioCare ASA's earnings per share (EPS) over the last twelve months is $-0.04, as of Jun 2026.
What was Hofseth BioCare ASA's earnings per share (EPS) in 2025?
In 2025, Hofseth BioCare ASA's earnings per share (EPS) was $-0.03, compared with $-0.03 in 2024.
How has Hofseth BioCare ASA's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Hofseth BioCare ASA's earnings per share (EPS) was highest in 2025 ($-0.03) and lowest in 2022 ($-0.04).
How does Hofseth BioCare ASA's earnings per share (EPS) compare with similar companies?
Hofseth BioCare ASA's earnings per share (EPS) ($-0.04) is lower than that of all 5 similar companies listed above. The highest among them is Nestlé S.A., with $3.49.